Goodman Noah
SEC CIK 2060075 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KYMR | Kymera Therapeutics, Inc. | Chief Business Off | 47.2K | — | $2.22M | 10 | 2025-04-08 | 2026-07-01 |
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-02 18:30 | 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | S - Sale | $114.29 | -3,389 | 47.2K | -7% | -$387.3K |
| DT | 2026-06-25 18:00 | 2026-06-25 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | M - OptEx | $21.05 | +5,000 | 55.2K | +10% | +$105.2K |
| DMT | 2026-06-25 18:00 | 2026-06-25 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | S - Sale+OE | $114.00 | -5,000 | 50.2K | -9% | -$570.0K |
| DT | 2026-06-22 17:47 | 2026-06-22 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | M - OptEx | $21.05 | +2,500 | 52.7K | +5% | +$52.6K |
| DT | 2026-06-22 17:47 | 2026-06-22 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | S - Sale+OE | $99.00 | -2,500 | 50.2K | -5% | -$247.5K |
| T | 2026-04-16 18:30 | 2026-04-14 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | S - Sale | $90.00 | -1,347 | 50.2K | -3% | -$121.2K |
| DT | 2026-04-10 16:45 | 2026-04-09 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | M - OptEx | $21.05 | +2,500 | 61.8K | +4% | +$52.6K |
| DMT | 2026-04-10 16:45 | 2026-04-09+ | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | S - Sale+OE | $87.47 | -10.3K | 51.5K | -17% | -$897.8K |
| D | 2026-03-04 | 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | A - Grant | $0.00 | +9,225 | 59.3K | +18% | $0 |
| D | 2025-04-09 | 2025-04-08 | KYMR | Kymera Therapeutics, Inc. | Goodman Noah | Chief Business Off | A - Grant | $0.00 | +50.0K | 50.1K | +61,395% | $0 |
Purchase Sale Sale after option exercise All abbreviations